MedTrace Logo

Diabetes Lifestyle Assessment and Educational Tools

NCT01858506 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-04-15

No results posted yet for this study

Summary

Aim: To evaluate a culturally-adapted method of lifestyle assessment, counseling, and education among Arab people with diabetes who have varying literacy skills using an interactive computerized tool and graphically-enhanced patient logs for dietary and physical activity.

The investigators hypothesize that this tool will: a) increase patients' knowledge and understanding of the role of lifestyle (diet and physical activity) in diabetes management; b) improve patients' engagement in monitoring dietary intake and physical activity; c) improve dietary and physical activity behaviors and self-blood glucose monitoring (SBGM) practices; d) improve glycemic control; and, e) improve the efficiency of lifestyle assessment, education and counseling while increasing patients' engagement in the process.

Conditions

Interventions

PROCEDURE

I-ACE intervention

lifestyle counselling using the interactive assessment, counselling and education (I-ACE)-based method.

PROCEDURE

Standard Lifestyle Advice

lifestyle counselling using the standard lifestyle advice (SLA) program currently provided to Clalit Health Services patients.

Sponsors & Collaborators

  • The Gertner Institute

    collaborator OTHER

  • Clalit Health Services

    collaborator OTHER

  • European Foundation for the Study of Diabetes

    collaborator OTHER

  • Ofra Kalter-Leibovici MD

    lead OTHER_GOV

Principal Investigators

  • Ofra Kalter-Leibovici, M.D. · Sheba Medical Center, the Gertner Institute for Epidemiology & Health Policy Research

  • Kathleen Abu-Saad, Ph.D. · Gertner Institute for Epidemiology & Health Policy Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2016-02-29
Completion
2016-03-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01858506 on ClinicalTrials.gov